Pfizer Whistleblower Suit Dismissed: US Army Buyer Means Normal Safety Standards Don’t Apply

On March 31, United States District Judge Michael J. Truncale ruled against Brook Jackson, the Pfizer whistleblower who was suing that firm and its clinical trial subcontractors on behalf of the US government for substantial irregularities it their clinical trials practices. TrialSite News last reported on this case here, after the oral arguments on Pfizer’s motion to dismiss were heard on March 1. The opinion in USA v. Ventavia Research Group, LLC; Pfizer, Inc; and ICON, PLC granted the motion to dismiss with prejudice Ms. Jackson’s “presentment” and false record claims, the heart of the case. Judge Truncale also dismissed a retaliatory firing claim without prejudice, meaning this claim could possibly be refiled under a different legal theory. For a motion to dismiss, the court assumes as true the facts alleged by a plaintiff and then decides whether said facts amount to a legally cognizable claim. In one aspect of this ruling, the judge noted that the COVID-19 vaccine contracts at issue involved the Department of Defense
------------------------------------
Join The Conversation! | https://trialsitenews.com/